Dose reduction and discontinuation of disease‐modifying anti‐rheumatic drugs (DMARDs) for juvenile idiopathic arthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dose Reduction and Discontinuation of Disease‐modifying Anti‐rheumatic Drugs (DMARDs) for Juvenile Idiopathic Arthritis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432015/all/images/ios-appstore-badge.png. Accessed 30 April 2024.
Dose reduction and discontinuation of disease‐modifying anti‐rheumatic drugs (DMARDs) for juvenile idiopathic arthritis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432015/all/images/ios-appstore-badge.png. Accessed April 30, 2024.
Dose reduction and discontinuation of disease‐modifying anti‐rheumatic drugs (DMARDs) for juvenile idiopathic arthritis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432015/all/images/ios-appstore-badge.png
Dose Reduction and Discontinuation of Disease‐modifying Anti‐rheumatic Drugs (DMARDs) for Juvenile Idiopathic Arthritis [Internet]. In: Cochrane Abstracts. [cited 2024 April 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432015/all/images/ios-appstore-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dose reduction and discontinuation of disease‐modifying anti‐rheumatic drugs (DMARDs) for juvenile idiopathic arthritis
ID - 432015
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432015/all/images/ios-appstore-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -